Analyst Ratings for Silence Therapeutics (SLN)
SLN Rating Summary
SLN Price Target Summary
- Highest: $75.00 (H.C. Wainwright)
- Lowest: $25.00 (Jefferies)
- Average: $50.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.00 (+376.2%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
Avg. $ Target:
$50.00 (+376.2%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2026 | Cantor Fitzgerald | Prakhar Agrawal | New Coverage | Overweight (N/A) |
N/A (N/A) |
7.27 (10.50) |
44.43% | Details |
| 2/11/2025 | Goldman Sachs » Updated 3/3/2025 |
Richard Law | New Coverage | Sell (N/A) |
4.00 (6.00) |
5.01 (10.50) |
109.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
